Abstract
Objective
To evaluate the clinical value of transrectal ultrasound guided systematic 13-core prostate biopsy.
Methods
A total of 213 patients referred for abnormal digital rectal examination and/or with a prostate specific antigen of 4 ng/ml or greater underwent transrectal ultrasound guided systematic 13-core prostate biopsy. This procedure was conducted in addition to the standard sextant biopsies in which cores were taken from the far lateral and middle regions of the gland as described by Eskew. Pathological findings of the additional regions were compared with those of the sextant regions.
Results
Of the 213 patients 31% had cancer on biopsy (66/213). Of the 66 patients with prostate cancer 14 (21%) had carcinoma only in the additional regions, which would have remained undetected had the sextant biopsy technique been used alone (P<0.05). No severe complications occurred among the patients who underwent transrectal ultrasound guided systematic 13-core prostate biopsy.
Conclusion
Our data demonstrated that transrectal ultrasound guided systematic 13-core prostate biopsy can significantly increase the cancer detection rate. It is safe and efficacious, and should be recommended for use clinically.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Norberg M, Egevad L, Holmberg L, et al. The sextant protocol for ultrasound guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997; 50: 562–566.
Vashi AR, Wojno KJ, Gillespie B, et al. A model for the number of cores per prostate biopsy based on patient age and prostate volume. J Urol. 1998; 159:920–923.
Babaian RJ. Extended field prostate biopsy enhances cancer detetion. Urology. 2000; 55:453–456.
Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997; 157:199–202.
Naughton CK, Miller DC, Mager DE, et al. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol. 2000; 164:388–392.
Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989; 142:71–74.
Karakiewicz PI, Bazinet M, Aprikian AG, et al. Outcome of sextant biopsy according to gland volume. Urology. 1997; 49:55–59.
Uzzo RG, Wei JT, Waldbaum RS, et al. The influence of prostate size on cancer detection. Urology. 1995; 46:831–836.
Stamey TA. Making the most out of six systematic sextant biopsies. Urology. 1995; 45:2–12.
Hammerer P, and Huland H. Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol. 1994; 151:99–102.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yang, L., Deng, J., Zhong, H. et al. Transrectal ultrasound-guided systematic 13-core prostate biopsy to diagnose prostate carcinoma. Chin. J. Clin. Oncol. 2, 849–851 (2005). https://doi.org/10.1007/BF02789652
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02789652